0000921895-24-000042.txt : 20240103 0000921895-24-000042.hdr.sgml : 20240103 20240103171724 ACCESSION NUMBER: 0000921895-24-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cote Jennifer CENTRAL INDEX KEY: 0001960481 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 24508143 MAIL ADDRESS: STREET 1: C/O HARVARD BIOSCIENCE, INC. STREET 2: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 4 1 form412799001cot_01032024.xml OWNERSHIP DOCUMENT X0508 4 2023-12-29 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001960481 Cote Jennifer C/O HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL ROAD HOLLISTON MA 01746 1 1 0 0 Chief Financial Officer 0 Common Stock 2023-12-29 4 F 0 3279 5.35 D 109689 D Common Stock 2023-12-29 4 F 0 2631 5.35 D 107058 D The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023. Includes (a) 17,928 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 11,171 restricted stock units that will vest on December 29, 2024, (c) 25,862 restricted stock units with performance based vesting conditions tied to relative total shareholder return, (d) 29,880 restricted stock units that will vest on March 6, 2024 and (e) 22,217 shares of common stock beneficially owned by the Reporting Person. /s/ David Sirois, by power of attorney 2024-01-03